Carcinoid tumours in the abdomen are uncommon, but typically occur in the gastrointestinal tract. Primary renal carcinoid is an extremely rare tumour, poorly described in the literature. We describe an unusual case where an atypical renal mass on imaging led to a preoperative diagnosis of renal carcinoid on imaging guiding biopsy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

renal carcinoid
12
primary renal
8
carcinoid
4
carcinoid case
4
case report
4
report carcinoid
4
carcinoid tumours
4
tumours abdomen
4
abdomen uncommon
4
uncommon typically
4

Similar Publications

Horseshoe kidney is a rare congenital anomaly with an unusually higher frequency of neuroendocrine tumors. Symptoms are rare, and, in most of the cases, are incidentally diagnosed. The clinical behavior of these tumors is heterogeneous and can be difficult to predict based on histology alone.

View Article and Find Full Text PDF

Introduction: Choroidal metastases from systemic malignancies are the most common intraocular malignancies in adults. External beam radiation (EBR) has historically been first-line therapy for metastatic tumors to the choroid. However, good responses have been described with newer targeted biologics.

View Article and Find Full Text PDF

Primary renal neuroendocrine tumors (NETs) are extremely rare among renal malignancies. According to pathological manifestations, carcinoid can be divided into four types: typical carcinoid, atypical carcinoid, large cell and small cell neuroendocrine carcinoma. Primary or secondary retroperitoneal carcinoid is even rarer than renal carcinoid.

View Article and Find Full Text PDF
Article Synopsis
  • * The study highlights three patients with metastatic pituitary lesions linked to primary cancers of the breast, lung, and kidney, all of whom had surgical treatment at an endocrinology research center.
  • * Symptoms included panhypopituitarism and chiasmal syndrome, with varying outcomes; two patients experienced disease progression while one maintained a stable condition after surgery.
View Article and Find Full Text PDF
Article Synopsis
  • Octreotide is a synthetic version of somatostatin that helps inhibit hormones like growth hormone and insulin, and is used in conditions such as acromegaly and carcinoid tumors.
  • A 44-year-old man with type 2 diabetes and advanced kidney disease experienced severe hypoglycemia from sulfonylureas and was treated with octreotide, which unfortunately caused hyperkalemia as a side effect.
  • This case underscores the risks of using octreotide in patients with renal impairment, highlighting the need for careful monitoring of potassium levels to prevent serious complications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!